Journal of Hematology & Oncology

official impact factor 2.93

Open Access Highly Access Review

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

RuiRong Yuan*, Andrea Kay, William J Berg and David Lebwohl

Journal of Hematology & Oncology 2009, 2:45 doi:10.1186/1756-8722-2-45

No comments have yet been made on this article.

Post a comment